Byeong Geun Seok
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Byeong Geun Seok has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Su Wol Chung
Department of Biological Sciences, College of Natural Sciences, University of Ulsan, Ulsan, 44610, South Korea; Brain Korea 21 Project, University of Ulsan College of Medicine, University of Ulsan, Seoul, 05505, South Korea; Basic-Clinical Convergence Research Institute, University of Ulsan, Ulsan, 44610 South Korea
4 shared publications Sangguk Lee
Department of Biological Sciences, College of Natural Sciences, University of Ulsan, Ulsan, 44610, South Korea
2 shared publications- Seon-Jin Lee
Environmental Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea
2 shared publications - Seunghee Lee
VA Palo Alto Health Care System, Palo Alto, CA (D.K., W.T., M.X., R.V., J.L.C., S.G., S.L., Y.Z., T.G., E.C.S., E.B., J.P., X.J., M.R.N.).
2 shared publications Eunhee Park
Department of Biological Sciences, College of Natural Sciences, University of Ulsan, Ulsan 44610,Korea
1 shared publicationHyuk Nam Kwon
Department of Biological Sciences, College of Natural Sciences, University of Ulsan, Ulsan, 44610, South Korea
1 shared publication
Latest Publications
- Open Access
- 23 June 2025
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 238, 293-302
Inhibiting mitoNEET restores mitochondrial redox homeostasis and attenuates myofibroblast differentiation
- 23 June 2025
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 238, 293-302
Open AccessInhibiting mitoNEET restores mitochondrial redox homeostasis and attenuates myofibroblast differentiation
- Open Access
- 22 January 2025
- Published by Korean Society for Biochemistry and Molecular Biology - BMB Reports in BMB Reports
- Vol. 58 (2) , 89-94
PGC1α is a key regulator of erastin-induced mitochondrial dysfunction during ferroptotic cell death
Byeong Geun Seok, Eunhee Park, Young-Jun Park, Hyuk Nam Kwon, Su Wol Chung . BMB Reports -0001;0:. https://doi.org/10.5483/BMBRep.2024-0139
- 22 January 2025
- Published by Korean Society for Biochemistry and Molecular Biology - BMB Reports in BMB Reports
- Vol. 58 (2) , 89-94
Open AccessPGC1α is a key regulator of erastin-induced mitochondrial dysfunction during ferroptotic cell death
Byeong Geun Seok, Eunhee Park, Young-Jun Park, Hyuk Nam Kwon, Su Wol Chung . BMB Reports -0001;0:. https://doi.org/10.5483/BMBRep.2024-0139
- Top Cited PapersOpen Access
- 25 July 2023
- Published by Springer Nature in Cell Death & Disease
- Vol. 14 (7) , 1-10
Autophagy mediates an amplification loop during ferroptosis
Ferroptosis, a programmed cell death, has been identified and associated with cancer and various other diseases. Ferroptosis is defined as a reactive oxygen species (ROS)-dependent cell death related to iron accumulation and lipid peroxidation, which is different from apoptosis, necrosis, autophagy, and other forms of cell death. However, accumulating evidence has revealed a link between autophagy and ferroptosis at the molecular level and has suggested that autophagy is involved in regulating the accumulation of iron-dependent lipid peroxidation and ROS during ferroptosis. Understanding the roles and pathophysiological processes of autophagy during ferroptosis may provide effective strategies for the treatment of ferroptosis-related diseases. In this review, we summarize the current knowledge regarding the regulatory mechanisms underlying ferroptosis, including iron and lipid metabolism, and its association with the autophagy pathway. In addition, we discuss the contribution of autophagy to ferroptosis and elucidate the role of autophagy as a ferroptosis enhancer during ROS-dependent ferroptosis.
- 25 July 2023
- Published by Springer Nature in Cell Death & Disease
- Vol. 14 (7) , 1-10
Top Cited PapersOpen AccessAutophagy mediates an amplification loop during ferroptosis
Ferroptosis, a programmed cell death, has been identified and associated with cancer and various other diseases. Ferroptosis is defined as a reactive oxygen species (ROS)-dependent cell death related to iron accumulation and lipid peroxidation, which is different from apoptosis, necrosis, autophagy, and other forms of cell death. However, accumulating evidence has revealed a link between autophagy and ferroptosis at the molecular level and has suggested that autophagy is involved in regulating the accumulation of iron-dependent lipid peroxidation and ROS during ferroptosis. Understanding the roles and pathophysiological processes of autophagy during ferroptosis may provide effective strategies for the treatment of ferroptosis-related diseases. In this review, we summarize the current knowledge regarding the regulatory mechanisms underlying ferroptosis, including iron and lipid metabolism, and its association with the autophagy pathway. In addition, we discuss the contribution of autophagy to ferroptosis and elucidate the role of autophagy as a ferroptosis enhancer during ROS-dependent ferroptosis.
- Open Access
- 8 February 2022
- Published by Springer Nature in Cell Death & Disease
- Vol. 13 (2) , 1-9
Inhibition of mitoNEET attenuates LPS-induced inflammation and oxidative stress
MitoNEET (mitochondrial protein containing Asn–Glu–Glu–Thr (NEET) sequence) is a 2Fe–2S cluster-containing integral membrane protein that resides in the mitochondrial outer membrane and participates in a redox-sensitive signaling and Fe–S cluster transfer. Thus, mitoNEET is a key regulator of mitochondrial oxidative capacity and iron homeostasis. Moreover, mitochondrial dysfunction and oxidative stress play critical roles in inflammatory diseases such as sepsis. Increased iron levels mediated by mitochondrial dysfunction lead to oxidative damage and generation of reactive oxygen species (ROS). Increasing evidence suggests that targeting mitoNEET to reverse mitochondrial dysfunction deserves further investigation. However, the role of mitoNEET in inflammatory diseases is unknown. Here, we investigated the mechanism of action and function of mitoNEET during lipopolysaccharide (LPS)-induced inflammatory responses in vitro and in vivo. Levels of mitoNEET protein increased during microbial or LPS-induced sepsis. Pharmacological inhibition of mitoNEET using mitoNEET ligand-1 (NL-1) decreased the levels of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α in animal models of sepsis, as well as LPS-induced inflammatory responses by macrophages in vitro. Inhibition of mitoNEET using NL-1 or mitoNEET shRNA abrogated LPS-induced ROS formation and mitochondrial dysfunction. Furthermore, mitochondrial iron accumulation led to generation of LPS-induced ROS, a process blocked by NL-1 or shRNA. Taken together, these data suggest that mitoNEET could be a key therapeutic molecule that targets mitochondrial dysfunction during inflammatory diseases and sepsis.
- 8 February 2022
- Published by Springer Nature in Cell Death & Disease
- Vol. 13 (2) , 1-9
Open AccessInhibition of mitoNEET attenuates LPS-induced inflammation and oxidative stress
MitoNEET (mitochondrial protein containing Asn–Glu–Glu–Thr (NEET) sequence) is a 2Fe–2S cluster-containing integral membrane protein that resides in the mitochondrial outer membrane and participates in a redox-sensitive signaling and Fe–S cluster transfer. Thus, mitoNEET is a key regulator of mitochondrial oxidative capacity and iron homeostasis. Moreover, mitochondrial dysfunction and oxidative stress play critical roles in inflammatory diseases such as sepsis. Increased iron levels mediated by mitochondrial dysfunction lead to oxidative damage and generation of reactive oxygen species (ROS). Increasing evidence suggests that targeting mitoNEET to reverse mitochondrial dysfunction deserves further investigation. However, the role of mitoNEET in inflammatory diseases is unknown. Here, we investigated the mechanism of action and function of mitoNEET during lipopolysaccharide (LPS)-induced inflammatory responses in vitro and in vivo. Levels of mitoNEET protein increased during microbial or LPS-induced sepsis. Pharmacological inhibition of mitoNEET using mitoNEET ligand-1 (NL-1) decreased the levels of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α in animal models of sepsis, as well as LPS-induced inflammatory responses by macrophages in vitro. Inhibition of mitoNEET using NL-1 or mitoNEET shRNA abrogated LPS-induced ROS formation and mitochondrial dysfunction. Furthermore, mitochondrial iron accumulation led to generation of LPS-induced ROS, a process blocked by NL-1 or shRNA. Taken together, these data suggest that mitoNEET could be a key therapeutic molecule that targets mitochondrial dysfunction during inflammatory diseases and sepsis.